Recalls / Class II

Class IID-0202-2025

Product

glipiZIDE, Extended-Release Tablets, 2.5 mg, 30-count (3x10 blister cards) carton, Rx Only, Distributed by: American Health Packaging, Columbus, Ohio 43217, Carton NDC: 60687-480-21, Unit Dose NDC: 60687-480-11

Affected lot / code info

Lot # 1012910, Exp Date: 04/30/2025

Why it was recalled

Failed Dissolution Specifications:

Recalling firm

Firm

Amerisource Health Services LLC

Notification channel

Letter

Type

Voluntary: Firm initiated

Address

2550 John Glenn Ave Ste A, Columbus, Ohio 43217-1188

Distribution

Quantity

2,028 units (cartons of 30 individual unit doses)

Distribution pattern

Nationwide in the USA

Timeline

Recall initiated

2024-12-17

FDA classified

2025-01-16

Posted by FDA

2025-01-22

Status

Completed

Source: openFDA Drug Enforcement endpoint. Recall record D-0202-2025. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.